Dmitry Tumin1, Patrick I McConnell, Mark Galantowicz, Joseph D Tobias, Don Hayes. 1. 1 Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH. 2 Center for the Epidemiological Study of Organ Failure and Transplantation, Nationwide Children's Hospital, Columbus, OH. 3 Department of Anesthesiology & Pain Medicine, Nationwide Children's Hospital, Columbus, OH. 4 Department of Surgery, The Ohio State University College of Medicine Columbus, OH. 5 Department of Cardiothoracic Surgery, Nationwide Children's Hospital, Columbus, OH. 6 Department of Anesthesiology, The Ohio State University College of Medicine, Columbus, OH. 7 Department of Internal Medicine, The Ohio State University College of Medicine Columbus, OH. 8 Section of Pulmonary Medicine, Nationwide Children's Hospital, Columbus, OH.
Abstract
BACKGROUND: Young adult heart transplantation (HTx) recipients experience high mortality risk attributed to increased nonadherence to immunosuppressive medication in this age window. This study sought to test whether a high-risk age window in HTx recipients persisted in the absence of reported nonadherence. METHODS: Heart transplantation recipients aged 2 to 40 years, transplanted between October 1999 and January 2007, were identified in the United Network for Organ Sharing database. Multivariable survival analysis was used to estimate influences of age at transplantation and attained posttransplant age on mortality hazard among patients stratified by center report of nonadherence to immunosuppression that compromised recovery. RESULTS: Three thousand eighty-one HTx recipients were included, with univariate analysis demonstrating peak hazards of mortality and reported nonadherence among 567 patients transplanted between ages 17 and 24 years. Multivariable analysis adjusting for reported nonadherence demonstrated lower mortality among patients transplanted at younger (hazards ratio, 0.813; 95% confidence interval, 0.663-0.997; P = 0.047) or older (hazards ratio, 0.835; 95% confidence interval, 0.701-0.994; P = 0.042) ages. Peak mortality hazard at ages 17 to 24 years was confirmed in the subgroup of patients with no nonadherence reported during follow-up. This result was replicated using attained age after HTx as the time metric, with younger and older ages predicting improved survival in the absence of reported nonadherence. CONCLUSIONS: Late adolescence and young adulthood coincide with greater mortality hazard and greater chances of nonadherence to immunosuppressive medication after HTx, but the elevation of mortality hazard in this age range persists in the absence of reported nonadherence. Other causes of the high-risk age window for post-HTx mortality should be demonstrated to identify opportunities for intervention.
BACKGROUND: Young adult heart transplantation (HTx) recipients experience high mortality risk attributed to increased nonadherence to immunosuppressive medication in this age window. This study sought to test whether a high-risk age window in HTx recipients persisted in the absence of reported nonadherence. METHODS: Heart transplantation recipients aged 2 to 40 years, transplanted between October 1999 and January 2007, were identified in the United Network for Organ Sharing database. Multivariable survival analysis was used to estimate influences of age at transplantation and attained posttransplant age on mortality hazard among patients stratified by center report of nonadherence to immunosuppression that compromised recovery. RESULTS: Three thousand eighty-one HTx recipients were included, with univariate analysis demonstrating peak hazards of mortality and reported nonadherence among 567 patients transplanted between ages 17 and 24 years. Multivariable analysis adjusting for reported nonadherence demonstrated lower mortality among patients transplanted at younger (hazards ratio, 0.813; 95% confidence interval, 0.663-0.997; P = 0.047) or older (hazards ratio, 0.835; 95% confidence interval, 0.701-0.994; P = 0.042) ages. Peak mortality hazard at ages 17 to 24 years was confirmed in the subgroup of patients with no nonadherence reported during follow-up. This result was replicated using attained age after HTx as the time metric, with younger and older ages predicting improved survival in the absence of reported nonadherence. CONCLUSIONS: Late adolescence and young adulthood coincide with greater mortality hazard and greater chances of nonadherence to immunosuppressive medication after HTx, but the elevation of mortality hazard in this age range persists in the absence of reported nonadherence. Other causes of the high-risk age window for post-HTx mortality should be demonstrated to identify opportunities for intervention.
Authors: Sarah Streeter Hutcheson; Victoria Phillips; Rachel Patzer; Andrew Smith; J David Vega; Alanna A Morris Journal: Clin Transplant Date: 2018-07-11 Impact factor: 2.863
Authors: Dmitry Tumin; Jessica Horan; Emily A Shrider; Sakima A Smith; Joseph D Tobias; Don Hayes; Randi E Foraker Journal: Am Heart J Date: 2017-06-03 Impact factor: 4.749
Authors: Hasina Maredia; Mary Grace Bowring; Allan B Massie; Sunjae Bae; Amber Kernodle; Shakirat Oyetunji; Christian Merlo; Robert S D Higgins; Dorry L Segev; Errol L Bush Journal: Circ Heart Fail Date: 2021-02-02 Impact factor: 8.790
Authors: Mary Amanda Dew; Andrea F DiMartini; Fabienne Dobbels; Kathleen L Grady; Sheila G Jowsey-Gregoire; Annemarie Kaan; Kay Kendall; Quincy-Robyn Young Journal: Curr Heart Fail Rep Date: 2019-12
Authors: Johanna S van Zyl; Teena Sam; Donna M Clark; Joost Felius; Amanda K Doss; Kacie R Kerlee; Zi-On Cheung; Katalin Martits-Chalangari; Aayla K Jamil; Sandra A Carey; Robert L Gottlieb; Cesar Y Guerrero-Miranda; Parag Kale; Shelley A Hall Journal: Clin Transplant Date: 2021-10-01 Impact factor: 3.456